|
|
Thomson Financial Business Description:
| The Company's principal activity is to develop and markets products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. It operates in two segments; Biologic Drug Candidates and Biologic Tissue Product. Biologic Drug Candidates segment develops and markets product to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Biologic Tissue Product segment includes the manufacture and sale of Osteocel and is currently being used by orthopedic surgeons for focal bone repair. It operates in the United States. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Osiris Therapeutics, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
